Here, it was reported that type 2 diabetic patients orally administered with metformin (1,500 mg) or placebo in combination with intravenous infusion of cholecystokinin (CCK) (0.4 mol/kg/min) or saline, showed an enhanced plasma GLP-1. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.